This inventor holds 3 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Sanofi Pasteur Biologics, LLC, Sanofi Pasteur Inc.. Active years: 2018-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2024
Title: The Innovative Contributions of Natalie Anosova
Introduction
Natalie Anosova is a prominent inventor based in Lexington, MA, known for her significant contributions to the field of biotechnology. With a total of three patents to her name, she has made remarkable strides in developing monoclonal antibodies for medical applications.
Latest Patents
Anosova's latest patents include groundbreaking work on antibodies against Clostridium difficile toxins. These patents focus on monoclonal antibodies, or antigen-binding fragments, that specifically bind to toxin A or toxin B. The methods developed by Anosova aim to detect or treat infections and associated diseases effectively.
Career Highlights
Throughout her career, Anosova has worked with notable companies such as Sanofi Pasteur Biologics, LLC and Sanofi Pasteur Inc. Her work in these organizations has allowed her to advance her research and contribute to the development of innovative medical solutions.
Collaborations
Anosova has collaborated with esteemed colleagues, including Stephen F. Anderson and Nicola Beltraminelli. These partnerships have further enriched her research and expanded the impact of her inventions.
Conclusion
Natalie Anosova's work exemplifies the spirit of innovation in biotechnology. Her patents and collaborations highlight her commitment to advancing medical science and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile